Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) for Youth With Anxiety, ADHD, or Autistic Disorder View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2015-2019

ABSTRACT

Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont & Sofronoff, 2008; Tan, Mazzucchelli & Beaumont, submitted), school-(Beaumont, Rotolone & Sofronoff, in press; Einfeld et al., submitted) and remote Skype/telephone-assisted delivery contexts (Sofronoff, Silva & Beaumont, in press).The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder. Detailed Description Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic, school and remote Skype/telephone-assisted delivery contexts. Results from a pilot University clinic evaluation of the program for children with social-emotional difficulties but without ASD has also yielded positive findings, showing comparable treatment effects to those achieved for children with ASD in terms of improved social-emotional functioning. Within the USA, results from a two-year Buffalo School District implementation project and delivery of the program through USC University Center for Excellence in Developmental Disabilities (UCEDD Children's Hospital Los Angeles) have provided further support for the effectiveness and cross-cultural appropriateness of the intervention with children who have a range of mental health challenges. The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder. Outcome variables will include measures of child social functioning and mental health outcomes related to their primary diagnoses (e.g. anxiety, disruptive behaviour, etc). More... »

URL

https://clinicaltrials.gov/show/NCT02574273

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3177", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3468", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont & Sofronoff, 2008; Tan, Mazzucchelli & Beaumont, submitted), school-(Beaumont, Rotolone & Sofronoff, in press; Einfeld et al., submitted) and remote Skype/telephone-assisted delivery contexts (Sofronoff, Silva & Beaumont, in press).The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder.\n\nDetailed Description\nSeveral independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic, school and remote Skype/telephone-assisted delivery contexts. Results from a pilot University clinic evaluation of the program for children with social-emotional difficulties but without ASD has also yielded positive findings, showing comparable treatment effects to those achieved for children with ASD in terms of improved social-emotional functioning. Within the USA, results from a two-year Buffalo School District implementation project and delivery of the program through USC University Center for Excellence in Developmental Disabilities (UCEDD Children's Hospital Los Angeles) have provided further support for the effectiveness and cross-cultural appropriateness of the intervention with children who have a range of mental health challenges. The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder. Outcome variables will include measures of child social functioning and mental health outcomes related to their primary diagnoses (e.g. anxiety, disruptive behaviour, etc).", 
    "endDate": "2019-01-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT02574273", 
    "keywords": [
      "group treatment", 
      "Society Program", 
      "anxiety", 
      "ADHD", 
      "Autistic Disorder", 
      "independent evaluation", 
      "effectiveness", 
      "society", 
      "IN", 
      "child", 
      "Pervasive Child Development Disorder", 
      "Triacetoneamine-N-Oxyl", 
      "press", 
      "delivery", 
      "present study", 
      "utility", 
      "acceptability", 
      "skill training", 
      "social difficulty", 
      "mental health condition", 
      "developmental disorder", 
      "anxiety disorder", 
      "clinic", 
      "school", 
      "emotional difficulty", 
      "positive finding", 
      "treatment effect", 
      "USA", 
      "school district", 
      "Implementation Project", 
      "Center for Excellence", 
      "developmental disability", 
      "Children's Hospital", 
      "cultural appropriateness", 
      "intervention", 
      "health challenge", 
      "outcome variable", 
      "Weight and Measure", 
      "mental health outcome", 
      "diagnosise", 
      "disruptive behavior"
    ], 
    "name": "Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) for Youth With Anxiety, ADHD, or Autistic Disorder", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT02574273"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00020.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.5386.8", 
        "type": "Organization"
      }
    ], 
    "startDate": "2015-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1111/j.1469-7610.2008.01920.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008578427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10803-013-2014-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029255838", 
          "https://doi.org/10.1007/s10803-013-2014-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10803-013-2014-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029255838", 
          "https://doi.org/10.1007/s10803-013-2014-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT02574273"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02574273'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02574273'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02574273'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02574273'


 

This table displays all metadata directly associated to this object as RDF triples.

70 TRIPLES      16 PREDICATES      59 URIs      50 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT02574273 schema:about anzsrc-for:3177
2 anzsrc-for:3468
3 schema:description Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic- (Beaumont & Sofronoff, 2008; Tan, Mazzucchelli & Beaumont, submitted), school-(Beaumont, Rotolone & Sofronoff, in press; Einfeld et al., submitted) and remote Skype/telephone-assisted delivery contexts (Sofronoff, Silva & Beaumont, in press).The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder. Detailed Description Several independent evaluations have supported the effectiveness of the Secret Agent Society (SAS) Program in improving the social-emotional functioning of children with Autism Spectrum Disorders (ASD) in clinic, school and remote Skype/telephone-assisted delivery contexts. Results from a pilot University clinic evaluation of the program for children with social-emotional difficulties but without ASD has also yielded positive findings, showing comparable treatment effects to those achieved for children with ASD in terms of improved social-emotional functioning. Within the USA, results from a two-year Buffalo School District implementation project and delivery of the program through USC University Center for Excellence in Developmental Disabilities (UCEDD Children's Hospital Los Angeles) have provided further support for the effectiveness and cross-cultural appropriateness of the intervention with children who have a range of mental health challenges. The present study aims to extend on the above literature by conducting a 6-month randomized controlled trial evaluating the effectiveness, utility and acceptability (including cultural acceptability) of the Secret Agent Society (SAS) social-emotional skills training program. Specifically, the study aims to evaluate the effectiveness of the SAS Program for 8-12 year-old children with social difficulties in the context of a range of diagnosed mental health conditions and/or developmental disorders, including anxiety disorders, ADHD, and Autism Spectrum Disorder. Outcome variables will include measures of child social functioning and mental health outcomes related to their primary diagnoses (e.g. anxiety, disruptive behaviour, etc).
4 schema:endDate 2019-01-01T00:00:00Z
5 schema:keywords ADHD
6 Autistic Disorder
7 Center for Excellence
8 Children's Hospital
9 IN
10 Implementation Project
11 Pervasive Child Development Disorder
12 Society Program
13 Triacetoneamine-N-Oxyl
14 USA
15 Weight and Measure
16 acceptability
17 anxiety
18 anxiety disorder
19 child
20 clinic
21 cultural appropriateness
22 delivery
23 developmental disability
24 developmental disorder
25 diagnosise
26 disruptive behavior
27 effectiveness
28 emotional difficulty
29 group treatment
30 health challenge
31 independent evaluation
32 intervention
33 mental health condition
34 mental health outcome
35 outcome variable
36 positive finding
37 present study
38 press
39 school
40 school district
41 skill training
42 social difficulty
43 society
44 treatment effect
45 utility
46 schema:name Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) for Youth With Anxiety, ADHD, or Autistic Disorder
47 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02574273
48 schema:sdDatePublished 2019-03-07T15:26
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher Ne104f53bf2814e37beea178f1b680a16
51 schema:sponsor https://www.grid.ac/institutes/grid.5386.8
52 schema:startDate 2015-10-01T00:00:00Z
53 schema:subjectOf sg:pub.10.1007/s10803-013-2014-5
54 https://doi.org/10.1111/j.1469-7610.2008.01920.x
55 schema:url https://clinicaltrials.gov/show/NCT02574273
56 sgo:license sg:explorer/license/
57 sgo:sdDataset clinical_trials
58 rdf:type schema:MedicalStudy
59 Ne104f53bf2814e37beea178f1b680a16 schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 anzsrc-for:3177 schema:inDefinedTermSet anzsrc-for:
62 rdf:type schema:DefinedTerm
63 anzsrc-for:3468 schema:inDefinedTermSet anzsrc-for:
64 rdf:type schema:DefinedTerm
65 sg:pub.10.1007/s10803-013-2014-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029255838
66 https://doi.org/10.1007/s10803-013-2014-5
67 rdf:type schema:CreativeWork
68 https://doi.org/10.1111/j.1469-7610.2008.01920.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008578427
69 rdf:type schema:CreativeWork
70 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
 




Preview window. Press ESC to close (or click here)


...